Problem statement: Answer the multiple-choice question.
Question: Which drug has a -26.222% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) CC(=O)c1ccc(N(CC(=O)NC2CCCCC2)C(=O)c2csnn2)cc1
b) CCOc1cc(C2c3c(oc4ccccc4c3=O)C(=O)N2c2nccs2)ccc1O
c) O=C(Cc1ccc([N+](=O)[O-])cc1)N1CCN(c2ccc([N+](=O)[O-])cc2)CC1
d) CCOc1ccccc1N1C(=O)CC(Nc2ccc(N3CCOCC3)cc2)C1=O
e) CCOc1ccc(C(=O)NC(C)C2COc3ccccc3O2)cc1
Answer: e. CCOc1ccc(C(=O)NC(C)C2COc3ccccc3O2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(C(=O)NC(C)C2COc3ccccc3O2)cc1
CCOc1ccc(C(=O)NC(C)C2COc3ccccc3O2)cc1
N-[1-(2,3-dihydro-1,4-benzodioxin-3-yl)ethyl]-4-ethoxybenzamide